|
Volumn 36, Issue 2, 2004, Pages 309-311
|
Three-year experience in clinical intestinal transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
DACLIZUMAB;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
THYMOCYTE ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DIAGNOSTIC VALUE;
EARLY DIAGNOSIS;
FEMALE;
FIBERSCOPE ENDOSCOPY;
GARDNER SYNDROME;
GRAFT FAILURE;
GRAFT REJECTION;
HEALTH SURVEY;
HEMANGIOMATOSIS;
HUMAN;
IMAGE ANALYSIS;
INTESTINE ATRESIA;
INTESTINE BIOPSY;
INTESTINE INFARCTION;
INTESTINE ISCHEMIA;
INTESTINE OBSTRUCTION;
INTESTINE TRANSPLANTATION;
LIVER GRAFT;
MALE;
MEDICAL ASSESSMENT;
MEDICAL RECORD;
PATIENT MONITORING;
PRESCRIPTION;
PRIORITY JOURNAL;
RADIATION ENTEROPATHY;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TOTAL PARENTERAL NUTRITION;
TREATMENT OUTCOME;
WEANING;
ADULT;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL MUCOSA;
INTESTINE, SMALL;
INTESTINES;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 12144288771
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.01.106 Document Type: Conference Paper |
Times cited : (21)
|
References (5)
|